Cargando…

Correlation between tumor microenvironment-associated factors and the efficacy and prognosis of neoadjuvant therapy for rectal cancer

The tumor microenvironment contributes to the survival and development of tumor cells and is therefore a key target for cancer therapy. The tumor microenvironment has unique physical and chemical properties and is associated with inflammation and immunity. To examine the correlation between tumor mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Siyu, Bai, Wenqi, Tong, Xunan, Bu, Peng, Xu, Jing, Xi, Yanfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313063/ https://www.ncbi.nlm.nih.gov/pubmed/30655866 http://dx.doi.org/10.3892/ol.2018.9682

Ejemplares similares

Association of tumor differentiation and prognosis in patients with rectal cancer undergoing neoadjuvant chemoradiation therapy
por: Huang, Qunsheng, et al.
Publicado: (2019)

Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer
por: Lee, Hong Seok, et al.
Publicado: (2016)

GOLPH3 overexpression correlates with poor response to neoadjuvant therapy and prognosis in locally advanced rectal cancer
por: Zhu, Kunli, et al.
Publicado: (2016)

Retrospective research of neoadjuvant therapy on tumor-downstaging, post-operative complications, and prognosis in locally advanced rectal cancer
por: Li, Wen-Chang, et al.
Publicado: (2021)

Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy
por: Zhang, Lu-Ning, et al.
Publicado: (2015)

The effect of neoadjuvant chemotherapy on the tumor immune microenvironment in gastrointestinal tumors
por: Wang, Yujie, et al.
Publicado: (2022)

Neoadjuvant Therapy in Rectal Cancer - Biobanking of Preoperative Tumor Biopsies
por: Jo, Peter, et al.
Publicado: (2016)

Clinicopathological features, clinical efficacy on 101 cases of rectal gastrointestinal stromal tumors, and the significance of neoadjuvant therapy
por: Yang, Hongxin, et al.
Publicado: (2021)

The efficacy of adding targeted agents to neoadjuvant therapy for locally advanced rectal cancer patients: a meta‐analysis
por: Zhong, Xi, et al.
Publicado: (2018)

Delaying surgery after neoadjuvant chemoradiotherapy improves prognosis of rectal cancer
por: Mihmanlı, Mehmet, et al.
Publicado: (2016)

Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?
por: Deantonio, Letizia, et al.
Publicado: (2018)

High serum soluble CD155 level predicts poor prognosis and correlates with an immunosuppressive tumor microenvironment in hepatocellular carcinoma
por: Jin, An‐Li, et al.
Publicado: (2022)

Impact of age on efficacy of postoperative oxaliplatin-based chemotherapy in patients with rectal cancer after neoadjuvant chemoradiotherapy
por: Huang, Xuan-zhang, et al.
Publicado: (2016)

Impact of neoadjuvant treatment on rectal gastrointestinal stromal tumors
por: Cheong, Chinock, et al.
Publicado: (2022)

Efficacy of Imatinib Mesylate Neoadjuvant Treatment for a Locally Advanced Rectal Gastrointestinal Stromal Tumor
por: Yoon, Kyu Jong, et al.
Publicado: (2011)

Histopathological and Haemogram Features Correlate with Prognosis in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiation without Pathological Complete Response
por: Huang, Yu-Ming, et al.
Publicado: (2022)

Relation between skeletal muscle volume and prognosis in rectal cancer patients undergoing neoadjuvant therapy
por: De Nardi, Paola, et al.
Publicado: (2022)

Which is the best postoperative chemotherapy regimen in patients with rectal cancer after neoadjuvant therapy?
por: Gao, Peng, et al.
Publicado: (2014)

Identification of an Exosome-Related Signature for Predicting Prognosis, Immunotherapy Efficacy, and Tumor Microenvironment in Lung Adenocarcinoma
por: Lin, Tao, et al.
Publicado: (2022)

Significance of tumor‐infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer
por: Matsutani, Shinji, et al.
Publicado: (2018)

Tumor-Infiltrating Cytotoxic T Cells and Tumor-Associated Macrophages Correlate With the Outcomes of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Yang, Yuqin, et al.
Publicado: (2021)

Efficacy and safety of neoadjuvant imatinib therapy for patients with locally advanced rectal gastrointestinal stromal tumors: A multi-center cohort study
por: Li, Weihao, et al.
Publicado: (2022)

ypTNM category combined with AJCC tumor regression grade for screening patients with the worst prognosis after neoadjuvant chemoradiation therapy for locally advanced rectal cancer
por: Wei, Jiawang, et al.
Publicado: (2018)

Correlation between Baseline Conventional Ultrasounds, Shear-Wave Elastography Indicators, and Neoadjuvant Therapy Efficacy in Triple-Negative Breast Cancer
por: Wang, Siyu, et al.
Publicado: (2023)

Cuproptosis-Related genes in the prognosis of colorectal cancer and their correlation with the tumor microenvironment
por: Wu, Weiqiang, et al.
Publicado: (2022)

The correlation between tumor size, lymph node status, distant metastases and mortality in rectal cancer patients without neoadjuvant therapy
por: Luo, Dakui, et al.
Publicado: (2021)

Association of markers of systemic and local inflammation with prognosis of patients with rectal cancer who received neoadjuvant radiotherapy
por: Zhang, Xueqing, et al.
Publicado: (2018)

New tumor regression grade for rectal cancer after neoadjuvant therapy and radical surgery
por: Li, Jun, et al.
Publicado: (2015)

Interaction between intratumoral microbiota and tumor mediates the response of neoadjuvant therapy for rectal cancer
por: Sun, Lejia, et al.
Publicado: (2023)

Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis
por: Ho, Vincent, et al.
Publicado: (2018)

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
por: Molinari, Chiara, et al.
Publicado: (2011)

Clusterin is a biomarker of breast cancer prognosis and correlated with immune microenvironment
por: Yang, Ping, et al.
Publicado: (2023)

Cytokeratin 20 positive circulating tumor cells are a marker for response after neoadjuvant chemoradiation but not for prognosis in patients with rectal cancer
por: Hinz, Sebastian, et al.
Publicado: (2015)

Extramural depth of rectal cancer tumor invasion at thin-section MRI: predicting treatment response to neoadjuvant chemoradiation
por: Tong, Tong, et al.
Publicado: (2015)

SCD5 expression correlates with prognosis and response to neoadjuvant chemotherapy in breast cancer
por: Zhao, Weipeng, et al.
Publicado: (2021)

Skeletal muscle wasting and long-term prognosis in patients undergoing rectal cancer surgery without neoadjuvant therapy
por: Giani, Alessandro, et al.
Publicado: (2022)

Total neoadjuvant therapy for rectal cancer: evidence and challenge
por: Lee, Suk-Hwan
Publicado: (2023)

Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma
por: Deng, Chuangzhong, et al.
Publicado: (2020)

Feasibility and Efficacy of Neoadjuvant Chemotherapy without Radiotherapy for Locally Advanced Rectal Cancer
por: Tokuhara, Katsuji, et al.
Publicado: (2022)

An Immune-Related Gene Signature for Predicting Neoadjuvant Chemoradiotherapy Efficacy in Rectal Carcinoma
por: Qian, Liwen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vcqhnvgtcpsshln6cvlibgd3rc